The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Burden of invasive pneumococcal disease and serotype distribution among Streptococcus pneumoniae isolates in young children in Europe: impact of the 7-valent pneumococcal conjugate vaccine and considerations for future conjugate vaccines
Open accessAbstract
OBJECTIVES: The overall reported burden of invasive pneumococcal disease (IPD) varies among countries in Europe. This review describes the epidemiology and serotype distribution of IPD in European children from studies published from 1990 to 2008. METHODS: Averages were derived from all studies from all countries that had available data. RESULTS: Before widespread immunization with 7-valent pneumococcal conjugate vaccine (PCV7), the overall mean annual incidence of IPD in children aged <2 years was 44.4/100 000. The mean case fatality rate for IPD was 3.5%, and resistant rates were approximately 23% for penicillin G (minimum inhibitory concentration > or =2mg/l), 41% for erythromycin, and 9% (< or =5 years) for third-generation cephalosporins. The most common serotypes causing IPD were 14, 6B, 19F, and 23F, all of which are included in PCV7. Vaccine serotype coverage ranged from 37% to 100% for PCV7, with mean increases in coverage of 7% and 16% for investigational 10- and 13-valent pneumococcal conjugate vaccines, respectively. The most common IPD isolates since PCV7 introduction in Belgium, France, Germany, Greece, Norway, Portugal, Spain, and the UK were serotypes 1, 19A, 3, 6A, and 7F. CONCLUSIONS: With routine effective use of PCV7, a general decline in IPD, antibiotic non-susceptibility, and vaccine serotypes has been observed. The most common IPD isolates since PCV7 introduction are serotypes 1, 19A, 3, 6A, and 7F, highlighting the need for inclusion of these serotypes in future vaccine formulations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Performance standards for antimicrobial susceptibility testing
Ferraro, M. J. (2001) · Cited by 9,667
Haine, M. M.-L., & Meeùs, N. (1986) · Cited by 3,464
Whitney, C. G., Farley, M. M., Hadler, J., Harrison, L. H., Bennett, N. M., Lynfield, R., Reingold, A., Cieslak, P. R., Pilishvili, T., Jackson, D., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022823 · Cited by 2,228
Kyaw, M. H., Lynfield, R., Schaffner, W., Craig, A. S., Hadler, J., Reingold, A., Thomas, A. R., Harrison, L. H., Bennett, N. M., Farley, M. M., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa051642 · Cited by 881
Hausdorff, W. P., Bryant, J., Paradiso, P. R., & Siber, G. R. (2000) · Clinical Infectious Diseases · doi:10.1086/313608 · Cited by 866
Active Bacterial Core Surveillance of the Emerging Infections Program Network
Schuchat, A., Hilger, T., Zell, E., Farley, M. M., Reingold, A., Harrison, L., Lefkowitz, L., Danila, R., Stefonek, K., Barrett, N., et al. (2001) · Emerging Infectious Diseases · doi:10.3201/eid0701.010114 · Cited by 592
Discovery of a New Capsular Serotype (6C) within Serogroup 6 of Streptococcus pneumoniae
Park, I. H., Pritchard, D. G., Cartee, R., Brandao, A., Brandileone, M. C. C., & Nahm, M. H. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.02199-06 · Cited by 428
Munoz-Almagro, C., Jordan, I., Gene, A., Latorre, C., Garcia-Garcia, J. J., & Pallares, R. (2008) · Clinical Infectious Diseases · doi:10.1086/524660 · Cited by 333
Sleeman, K. L., Griffiths, D., Shackley, F., Diggle, L., Gupta, S., Maiden, M. C., Moxon, E. R., Crook, D. W., & Peto, T. E. A. (2006) · The Journal of Infectious Diseases · doi:10.1086/505710 · Cited by 259
Epidemiology of Invasive Pneumococcal Infections in Children in Finland
Eskola, J. (1992) · JAMA · doi:10.1001/jama.1992.03490230053027 · Cited by 253
Goossens, H., Ferech, M., Coenen, S., Stephens, P., & European Surveillance of Antimicrobial Consumption Project Group (2007) · Clinical Infectious Diseases · doi:10.1086/512810 · Cited by 227
Fenoll, A., Jado, I., Vicioso, D., Pérez, A., & Casal, J. (1998) · Journal of Clinical Microbiology · doi:10.1128/jcm.36.12.3447-3454.1998 · Cited by 211
Safety and Immunogenicity of a 13-Valent Pneumococcal Conjugate Vaccine
Bryant, K. A., Block, S. L., Baker, S. A., Gruber, W. C., Scott, D. A., & for the PCV13 Infant Study Group (2010) · Pediatrics · doi:10.1542/peds.2009-1405 · Cited by 186
Vestrheim, D. F., Løvoll, Ø., Aaberge, I. S., Caugant, D. A., Høiby, E. A., Bakke, H., & Bergsaker, M. R. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.03.087 · Cited by 162
Cohen, R., Levy, C., de La Rocque, F., Gelbert, N., Wollner, A., Fritzell, B., Bonnet, E., Tetelboum, R., & Varon, E. (2006) · Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000243163.85163.a8 · Cited by 158
Differential Effects of Pneumococcal Vaccines against Serotypes 6A and 6C
Park, I. H., Moore, M. R., Treanor, J. J., Pelton, S. I., Pilishvili, T., Beall, B., Shelly, M., Mahon, B. E., Nahm, M. H., & Active Bacterial Core Surveillance Team (2008) · The Journal of Infectious Diseases · doi:10.1086/593339 · Cited by 154
Calbo, E., Díaz, Á., Cañadell, E., Fábrega, J., Úriz, S., Xercavins, M., Morera, M.-A., Cuchí, E., Rodríguez‐Carballeira, M., Garau, J., et al. (2006) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2006.1502_1.x · Cited by 120
von Kries, R., Siedler, A., Schmitt, H. J., & Reinert, R. R. (2000) · Clinical Infectious Diseases · doi:10.1086/313984 · Cited by 117
Self-citationImmunogenicity, efficacy, safety and effectiveness of pneumococcal conjugate vaccines (1998–2006)
Kafeja, F., Beutels, P., & Damme, P. V. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.11.032 · Cited by 115
The roles of pneumococcal serotypes 1 and 5 in paediatric invasive disease
Hausdorff, W. P. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.09.009 · Cited by 115
Phase 1 trial of a 13-valent pneumococcal conjugate vaccine in healthy adults
Scott, D. A., Komjathy, S. F., Hu, B. T., Baker, S. A., Supan, L. A., Monahan, C. A., Gruber, W. C., Siber, G. R., & Lockhart, S. P. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.06.004 · Cited by 107
Theodoridou, M. N., Vasilopoulou, V. A., Atsali, E. E., Pangalis, A. M., Mostrou, G. J., Syriopoulou, V. P., & Hadjichristodoulou, C. S. (2007) · BMC Infectious Diseases · doi:10.1186/1471-2334-7-101 · Cited by 94
Epidemiology of invasive and other pneumococcal disease in children in England and Wales 1996-1998
Miller, E., Waight, P., Efstratiou, A., Brisson, M., Johnson, A. P., & George, R. (2000) · Acta Paediatrica · doi:10.1111/j.1651-2227.2000.tb00776.x · Cited by 94
Konradsen, H. B., & Kaltoft, M. S. (2002) · Clinical and Vaccine Immunology · doi:10.1128/cdli.9.2.358-365.2002 · Cited by 93
Herd immunity and pneumococcal conjugate vaccine: A quantitative model
Haber, M., Barskey, A. E., Baughman, W. S., Barker, L. E., Whitney, C. G., Shaw, K. M., Orenstein, W. A., & Stephens, D. S. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.04.088 · Cited by 89
Nielsen, S. V., & Henrichsen, J. (1996) · Epidemiology and Infection · doi:10.1017/s0950268800059057 · Cited by 89
Kaltoft, M., Zeuthen, N., & Hb, K. (2000) · Acta Paediatrica · doi:10.1111/j.1651-2227.2000.tb00775.x · Cited by 89
Ispahani, P. (2004) · Archives of Disease in Childhood · doi:10.1136/adc.2003.036921 · Cited by 81
Streptococcus pneumoniae in children in Spain: 1990-1999
Fenoll, A., Jado, I., Vicioso, D., Berrón, S., Yuste, J., & Casal, J. (2000) · Acta Paediatrica · doi:10.1111/j.1651-2227.2000.tb00783.x · Cited by 76
Effectiveness of the 7-Valent Pneumococcal Conjugate Vaccine: A Population-Based Case-Control Study
Barricarte, A., Castilla, J., Gil-Setas, A., Torroba, L., Navarro-Alonso, J.-A., Irisarri, F., & Arriazu, M. (2007) · Clinical Infectious Diseases · doi:10.1086/516779 · Cited by 74
6th International Symposium on Pneumococci and Pneumococcal Diseases
Ulloa‐Gutiérrez, R., & Avila-Aguero, M. L. (2008) · Expert Review of Vaccines · doi:10.1586/14760584.7.6.725 · Cited by 72
Kyaw, M. H., Christie, P., Clarke, S. C., et al. (2003) · Clinical Infectious Diseases · doi:10.1086/379016 · Cited by 70
Kronenberg, A., Zucs, P., Droz, S., & Mühlemann, K. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.00275-06 · Cited by 68
Pneumococcal conjugate vaccines—a European perspective
Reinert, R. R. (2004) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2004.04.004 · Cited by 63
Self-citationInternational Circumpolar Surveillance System for Invasive Pneumococcal Disease, 1999–2005
Bruce, M. G., Deeks, S. L., Zulz, T., Bruden, D. J. T., Navarro, C., Lovgren, M., Jetté, L. P., Kristinsson, K. G., Sigmundsdóttir, G., Jensen, K. B., et al. (2008) · Emerging infectious diseases · doi:10.3201/eid1401.071315 · Cited by 61
Pneumococcal meningitis in the era of pneumococcal conjugate vaccine implementation
Bingen, É., Lévy, C., Varon, E., ROCQUE, F. D. L., BOUCHERAT, M., d’Athis, P., Aujard, Y., Cohen, R., & The Bacterial Meningitis Study Group (2007) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-007-0417-y · Cited by 56
Serrano, I. D., The Portuguese Surveillance Group for the Study of Respiratory Pathogens, Ramirez, M., & Melo‐Cristino, J. (2004) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2004.00869.x · Cited by 51
D’Ancona, F. “., Salmaso, S., Barale, A., Boccia, D., Lopalco, P. L., Rizzo, C., Monaco, M., Massari, M., Demicheli, V., & Pantosti, A. (2004) · Vaccine · doi:10.1016/j.vaccine.2004.10.037 · Cited by 51
(2008) · PubMed · Cited by 51
Tzanakaki, G., & Mastrantonio, P. (2007) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2006.11.031 · Cited by 47
Dias, R. P. M., & Caniça, M. (2007) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.2007.00283.x · Cited by 45
Pneumococci Causing Invasive Disease in Britain 1982-1990
Colman, G., Cooke, E. M., Cookson, B. D., et al. (1998) · Journal of Medical Microbiology · doi:10.1099/00222615-47-1-17 · Cited by 44
Berg, S., Trollfors, B., Persson, E., Backhaus, E., Larsson, P., Ek, E., Claesson, B. E. B., Jönsson, L., Rådberg, G., Johansson, S., et al. (2006) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365540500532852 · Cited by 39
Systemic pneumococcal disease in Norway 1995–2001: capsular serotypes and antimicrobial resistance
Pedersen, M. K., Høiby, E. A., Frøholm, L. O., Hasseltvedt, V., Lermark, G., & Caugant, D. A. (2004) · Epidemiology and Infection · doi:10.1017/s0950268803001511 · Cited by 38
Epidemiology of pneumococcal infections in Swedish children
Eriksson, M., Henriques, B., & Ekdahl, K. (2000) · Acta Paediatrica · doi:10.1080/080352500300051521 · Cited by 36
Ihekweazu, C. A., Dance, D. A. B., Pebody, R. G., George, R. C., SMITH, M. D., Waight, P., CHRISTENSEN, H., Cartwright, K. A. V., & STUART, J. M. (2007) · Epidemiology and Infection · doi:10.1017/s0950268807009715 · Cited by 36
Flores, J. C., Fenoll, A., Berrón, S., Fernández, J. A., Rodrigo, C., Sánchez, J. M. M., & Pérez, C. F. (2002) · Anales de Pediatría · doi:10.1016/s1695-4033(02)77930-7 · Cited by 34
Johnson, A. P., Waight, P., Andrews, N. J., et al. (2007) · Journal of Infection · doi:10.1016/j.jinf.2007.07.009 · Cited by 31
Pantosti, A., Boccia, D., D’Ambrosio, F., Recchia, S., Orefici, G., & Moro, M. L. (2003) · Microbial Drug Resistance · doi:10.1089/107662903322541919 · Cited by 29
Epidemiology of Invasive Streptococcus pneumoniae Infections in Children in Spain, 1996–1998
Díez‐Domingo, J., Pereiró, I., Morant, A., Gimeno, C., Lerma, M., Oyagüez, I., & González, A. (2002) · Journal of Infection · doi:10.1053/jinf.2002.1051 · Cited by 29
Zissis, N., Syriopoulou, V., Kafetzis, D. A., Daikos, G., Tsilimingaki, A., Galanakis, E., & Tsangaropoulou, I. (2004) · European Journal of Pediatrics · doi:10.1007/s00431-004-1447-4 · Cited by 28
Pneumococcal bacteraemia in Belgium (1994 2004): the pre-conjugate vaccine era
Flamaing, J., Verhaegen, J., Vandeven, J., Verbiest, N., & Peetermans, W. E. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm435 · Cited by 27
Flamaing, J., Verhaegen, J., & Peetermans, W. E. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkf086 · Cited by 26
Magnus, T., & Andersen, B. M. (1995) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf02310362 · Cited by 24
Cochlear Implants and Meningitis in Children
Whitney, C. G. (2004) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000136818.94301.db · Cited by 24
McChlery, S. M., Scott, K. J., & Clarke, S. C. (2005) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-005-1313-y · Cited by 23
Control of pneumococcal disease in the United Kingdom – the start of a new era
Clarke, S. C. (2006) · Journal of Medical Microbiology · doi:10.1099/jmm.0.46579-0 · Cited by 19
Clarke, S. C., Jefferies, J. M., Smith, A. J., McMenamin, J., Mitchell, T. J., & Edwards, G. F. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.44.4.1224-1228.2006 · Cited by 14
Verhaegen, J., Vandecasteele, S. J., Vandeven, J., Verbiest, N., Lagrou, K., & Peetermans, W. E. C. (2003) · Acta Clinica Belgica · doi:10.1179/acb.2003.58.1.003 · Cited by 12
Épidémiologie et résistance aux antibiotiques de Streptococcus pneumoniae en Île de France en 2001
Demachy, M. C., Faibis, F., Artigou, A., Benoit, C., Cambau, E., Cécille, A., Chachaty, É., Chaplain, C., Cormier, P. J., Cousinard, F., et al. (2004) · Médecine et Maladies Infectieuses · doi:10.1016/j.medmal.2004.04.010 · Cited by 10
Flores, J., Fenoll, A., de Arístegui Fernández, J., et al. (2002) · PubMed · Cited by 9
Cited by
Harris, M., Clark, J., Coote, N., Fletcher, P., Harnden, A., McKean, M., Thomson, A., & On behalf of the British Thoracic Society Standards of Care Committee (2011) · Thorax · doi:10.1136/thoraxjnl-2011-200598 · Cited by 1,095
Streptococcus pneumoniae’s Virulence and Host Immunity: Aging, Diagnostics, and Prevention
Brooks, L. R. K., & Mias, G. I. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01366 · Cited by 286
Metadata
- Authors
- Isaacman, D. J., McIntosh, E. D., & Reinert, R. R.
- Venue
- International Journal of Infectious Diseases
- Publisher
- Elsevier BV
- Published
- 2010-03
- Volume
- 14
- Issue
- 3
- Pages
- e197-e209
- ISSN
- 1201-9712 (ISSN-L)
- OpenAlex
- W2089041217
- Cited by
- 321
- References
- 62
- FWCI
- 17.07
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.